-
IMPORTANT: In the next few weeks, we will be upgrading the message board software. We expect minimal downtime during the upgrade, and we will attempt to complete this during low-traffic hours. We will post an exact time several days ahead of the switch.Dismiss Notice
In preparation for the upgrade, we will be performing board maintenance, such as moving boards to Lost Civilizations where appropriate. Lost Civilizations is a category for companies that have either been dissolved or acquired. The boards serve as both an archive of the old company posts, as well as a place for former employees to reminisce or reconnect, as they will remain open for posting. We may also remove some board threads that have been inactive for several years.
Recent Posts
-
Sanofi reports positive data from Phase II asthma treatment trial
via Sanofi has announced positive outcomes from a Phase II clinical trial of rilzabrutinib, an oral treatment for adults with uncontrolled moderate-to-severe asthma. The double-blind, randomised, placebo-controlled, parallel-group trial analysed...
-
AstraZeneca’s $80B sales goal by 2030 reflects industry’s penchant for long-term bets
via This week, AstraZeneca embarked on a path to bring in $80 billion in sales by 2030. Achieving the ambition will require many moving parts to come together by then, most importantly a series of cancer drugs the company anticipates will achieve...
-
Drug shortages, cost concerns and iffy access — how DTC and telehealth could even the...
via A combination of telemedicine and DTC drug sales could more directly connect patients to the supply chain, helping to resolve drug shortages and potentially drive down out-of-pocket costs, said Peter Ax, CEO of UpScriptHealth, a telehealth...
-
Chinese firm throws lifeline to Pfizer UK plant workers
via China’s Asymchem Laboratories has agreed to take over the operation of a Pfizer UK manufacturing facility in Sandwich, Kent, safeguarding dozens of jobs. article source
-
AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies
via Days after AstraZeneca set out how new oncology drugs would help fuel its “bold” ambition to almost double its revenue by the end of the decade, the Big Pharma has further swelled this pipeline via a deal with Harbour BioMed subsidiary Nona...
-
The 50 REPS at Iveric BIO are better than you!
Why don’t you have your attorneys send out some more cease and desist letters to doctor that have experienced vasculitis while trying your product. Better yet, why not tell the world from the stage that vasculitis doesn’t exist with your product...
-
- + Show More
-
General Discussion
Discussion boards of general interest for those in the pharma, biotech, medical device, and related industries
-
Pharma/Biotech Companies
Anonymous discussion boards for pharmaceutical and biotech companies
-
Regional Discussion and Job Opportunities
Discussion and job opportunities by region
-
Lost Civilizations
Anonymous discussion boards for pharma/medical companies that no longer exist due to acquisition or other factors
-
Laboratory/Diagnostic Sales
Anonymous discussion boards for lab sales/diagnostics companies
-
Animal Health Sales
Anonymous discussion boards for animal health companies
-
Medical Equipment/Device Sales
Anonymous discussion boards for medical equipment/device companies
-
Pharmacies
Anonymous boards for pharmacy employees
-
PBMs
Anonymous discussion boards for PBMs
-
Pharma/Healthcare Marketing Agencies
Anonymous discussion boards for pharma/healthcare marketing agencies
-
Dental Reps
Anonymous discussion boards for dental health companies
-
Managed Care Specialists
Anonymous discussion boards for managed care specialists
-
Pharma IT
Anonymous discussion boards for pharma IT employees